Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 nov. 2012 19h34 HE | Source: Pluri Inc.

Pluristem Comments on Article Published on Bloomberg

HAIFA, Israel, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, offered comments on an article published...
08 nov. 2012 09h29 HE | Source: Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics to Present at the 2012 Jefferies Global Healthcare Conference in London

CARMIEL, Israel, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE:PLX) (TASE:PLX), today announced that Yossi Maimon, the Company's Vice President and Chief Financial Officer,...
07 nov. 2012 16h00 HE | Source: Powerfleet, Inc.

I.D. Systems Reports Record Quarterly Revenue and Net Income

WOODCLIFF LAKE, N.J., Nov. 7, 2012 (GLOBE NEWSWIRE) -- I.D. Systems, Inc. (Nasdaq:IDSY), a leading provider of wireless solutions for tracking, securing and managing high-value enterprise assets,...
07 nov. 2012 06h00 HE | Source: Pluri Inc.

Pluristem Completes Large Scale Cell Therapy Formulation for Commercial and Clinical Trial Use

HAIFA, Israel, Nov. 7, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today the Company has...
06 nov. 2012 14h30 HE | Source: BioLight - Israeli Life Sciences Investments Ltd.

BioLight Life Sciences Investments Ltd and Aerie Pharmaceuticals Affiliates Announce a Collaboration for Continued Development of a Controlled-Release Ocular Implant for the Delivery of Ophthalmic Medications

TEL AVIV, Israel & BEDMINSTER, N.J., Nov. 6, 2012 (GLOBE NEWSWIRE) -- ViSci Ltd., a wholly owned subsidiary of BioLight Ltd. (TASE:BOLT) entered into an option agreement with Novaer LLC, an...
05 nov. 2012 06h00 HE | Source: Retalix Ltd.

Retalix Schedules Date for Third Quarter 2012 Financial Results and Conference Call

RA'ANANA, Israel, Nov. 5, 2012 (GLOBE NEWSWIRE) -- Retalix® Ltd. (Nasdaq:RTLX), will announce its third quarter 2012 financial results on Wednesday, November 14, 2012. Following the earnings...
01 nov. 2012 10h33 HE | Source: Protalix BioTherapeutics, Inc.

European Commission Issues Decision on Taliglucerase Alfa Marketing Authorization Application

NEW YORK and CARMIEL, Israel, Nov. 1, 2012 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX, TASE:PLX) today announced that the European Commission (EC) has...
24 oct. 2012 08h28 HE | Source: Gilat Satellite Networks Ltd.

Gilat's Third Quarter 2012 Earnings Announcement Schedule

PETAH TIKVA, Israel, Oct. 24, 2012 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq:GILT) (TASE:GILT), a worldwide leader in satellite networking technology, solutions and services, today...
23 oct. 2012 10h05 HE | Source: BrainsWay Ltd.

Brainsway's Deep TMS System to be Marketed and Distributed in Nordic Countries

JERUSALEM, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce the execution of an agreement for the marketing and distribution of its Deep TMS device in Nordic...
23 oct. 2012 03h00 HE | Source: Pluri Inc.

Pluristem Achieves Milestone Towards Completion of Its New GMP Manufacturing Facility for Commercial Production of PLX Cells

HAIFA, Israel, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today a milestone in the...

Page précédente

Page suivante